-
公开(公告)号：KR1020130075845A
公开(公告)日：2013-07-08
申请号：KR1020110144110
申请日：2011-12-28
Applicant: 한림대학교 산학협력단
IPC: C12N15/12 , A01K67/027
Abstract: PURPOSE: Mcl-1 signal transduction can be easily used for the experiment for the verifying. CONSTITUTION: pCAGIG-Mcl-1 recombination gene the Escherichia coli to the host and it is the keen in the over-producing. The marker gene is the GFP expressed gene and/or the carbenicillin resistance gene. Provided is a method of being characterized by the research about the technology which makes the disease animal model of the brain nerve development step in the embryonic period mouse brain after the injection the pCAGIG-Mcl-1 recombination gene. Animal is the embryonic period (E15.5) mouse.
Abstract translation: 目的：Mcl-1信号转导可用于验证实验。 构成：pCAGIG-Mcl-1重组基因将大肠杆菌转移至宿主，并且是过度生产的热衷。 标记基因是GFP表达基因和/或羧苄青霉素抗性基因。 提供了一种通过对注射pCAGIG-Mcl-1重组基因后的胚胎期小鼠脑中脑神经发育步骤的疾病动物模型的技术的研究的特征。 动物是胚胎期（E15.5）小鼠。
-
2.发明公开
公开(公告)号：KR1020130079731A
公开(公告)日：2013-07-11
申请号：KR1020120000394
申请日：2012-01-03
Applicant: 한림대학교 산학협력단
IPC: A01K67/027 , C12N5/10
CPC classification number: A01K67/027 , A01K2217/206
Abstract: PURPOSE: A disease model animal development which includes a human cerebrum heterotopia by using a cerebrum micro-generic injection is provided to be widely used for a research of diseases which includes a human brain heterotopia by using the same. CONSTITUTION: A disease model animal development includes a human cerebrum heterotopia which uses a lysophosphatide receptor over-expression. An embryonic period (E13.5) mouse is provided as an animal which is used for a disease model animal. The above-mentioned method is a research about a technology which develops a disease animal model by injecting a specific gene into a cerebral ventricle.
Abstract translation: 目的：提供一种通过使用大脑微型注射液包括人脑异位症的疾病模型动物发育，被广泛用于包括使用它的人类脑异位症的疾病的研究。 构成：疾病模型动物发育包括使用溶血磷脂受体过表达的人类大脑异位症。 提供胚胎期（E13.5）小鼠作为用于疾病模型动物的动物。 上述方法是关于通过将特定基因注射到脑室中发展疾病动物模型的技术的研究。
-
公开(公告)号：KR1020130061391A
公开(公告)日：2013-06-11
申请号：KR1020110127674
申请日：2011-12-01
Applicant: 한림대학교 산학협력단
Abstract: PURPOSE: An anticancer composition using an active ingredient of a Dianthus chinensis L. var. chinensis extract is provided to be used as an anticancer composition for various diseases, and to be contributed to people's health. CONSTITUTION: An anticancer composition containing a Dianthus chinensis L. var. chinensis extract which is prepared from Dianthus chinensis L. var. chinensis using one or more solvents selected from a group consisting of water and C1-C5 alcohols. The active ingredient of Dianthus chinensis L. var. chinensis extract is prepared using 50-95%(w/v) ethanol. A method for manufacturing the anticancer composition comprises: a step of adding 5-20 times weight of ethanol to Dianthus chinensis L. var. chinensis plants; a step of extracting at 50-100 deg. C for 1-10 hours; and a step of filtering and evaporating the extract. A health functional food composition contains the anticancer composition.
Abstract translation: 目的：使用石竹属活性成分的抗癌成分。 提供中华萃取物作为各种疾病的抗癌成分，为人们的健康作出贡献。 构成：含有石竹属植物的抗癌成分。 中华叶提取物，由石竹属 使用一种或多种选自水和C 1 -C 5醇的溶剂。 石竹的活性成分 使用50-95％（w / v）乙醇制备中华提取物。 制造抗癌组合物的方法包括：向石竹中加入5-20倍重量乙醇的步骤。 中华植物; 在50-100度提取的步骤。 C 1-10小时; 以及过滤和蒸发提取物的步骤。 健康功能食品组合物含有抗癌成分。
-
公开(公告)号：KR1020120000246A
公开(公告)日：2012-01-02
申请号：KR1020100060503
申请日：2010-06-25
Applicant: 한림대학교 산학협력단
Abstract: PURPOSE: An anti-cancer composition containing Caryophyllaceae plant extract and a food composition containing the same are provided to induce rat-2 fibroblast and B103 apoptosis. CONSTITUTION: An anti-cancer composition contains Melandrium firmum extract as an active ingredient, extracted using water and alcohol of 1-5 carbon atoms at 50-100°C for 30 minutes to 12 hours. The extract is isolated from Melandrium firmum root using 10-95%(v/v) methanol. Melandrium firmum includes Melandrium Apricum, Melandrium Capitarum, or Melandrium Seoulensis. A health food contains the anti-cancer composition and supplementary food and further contains a proper carrier, excipient, and diluent.
Abstract translation: 目的：提供含有Caryophyllaceae植物提取物和含有它们的食品组合物的抗癌组合物，以诱导大鼠-2成纤维细胞和B103细胞凋亡。 构成：抗癌组合物含有Melonrium坚果提取物作为活性成分，使用1-5个碳原子的水和醇在50-100℃下萃取30分钟至12小时。 使用10-95％（v / v）甲醇从Melandrium坚果根分离提取物。 枸杞子包括枸杞，Melonrium Capitarum或Melonrium Seoulensis。 保健食品含有抗癌成分和补充食品，并含有适当的载体，赋形剂和稀释剂。
-
公开(公告)号：KR1020120000240A
公开(公告)日：2012-01-02
申请号：KR1020100060491
申请日：2010-06-25
Applicant: 한림대학교 산학협력단
IPC: A61K36/232 , A61K36/23 , A61P35/00
Abstract: PURPOSE: An anti-cancer composition using Angelica polymorpha root extract is provided to induce B103(neuroblastoma) apoptosis and to ensure anti-cancer effect. CONSTITUTION: An anti-cancer composition contains Angelica polymorpha extract as an active ingredient, which is extracted using water and alcohols of 1-5 carbon atoms. The Angelica polymorpha extract is prepared from Angelica decursiva flowers using 10-95%(v/v) methanol. A method for preparing the anti-cancer composition comprises: a step of preparing dried Angelica polymorpha plants; and a step of extracting the plants at 50-100°C for 1-10 hours to prepare water soluble liquid.
Abstract translation: 目的：提供使用当归多形性根提取物的抗癌成分，诱导B103（神经母细胞瘤）细胞凋亡并确保抗癌作用。 构成：抗癌组合物含有当归多形汉提取物作为活性成分，使用1-5个碳原子的水和醇提取。 使用10-95％（v / v）甲醇，从当归果皮花中制备当归多形汉逊酵素提取物。 制备抗癌组合物的方法包括：制备干燥的当归多形植物植物的步骤; 以及在50-100℃下提取植物1-10小时以制备水溶性液体的步骤。
-
Patent Agency Ranking
公开(公告)号：KR1020130025602A
公开(公告)日：2013-03-12
申请号：KR1020110089007
申请日：2011-09-02
Applicant: 한림대학교 산학협력단
IPC: A61K36/605 , A61P35/00
CPC classification number: A61K36/605 , A23L33/105 , A23V2200/308 , A61K2039/585 , A61K2236/33
Abstract: PURPOSE: An anticancer composition containing oxyresveratrol is provided to suppress cancer cell proliferation. CONSTITUTION: An anticancer composition containing oxyresveratrol is prepared using one or more kinds of solvents selected from water and C1-C4 alcohol. The extract is prepared by extracting with 60-95%(v/v) ethanol at 50-100 deg. C. for 1-10 hours, filtering the extract, and evaporating the ethanol.
Abstract translation: 目的：提供含有羟基维生素的抗癌组合物，以抑制癌细胞增殖。 构成：使用一种或多种选自水和C1-C4醇的溶剂制备含有氧基白藜芦醇的抗癌组合物。 通过在50-100℃下用60-95％（v / v）乙醇萃取来制备提取物。 C. 1-10小时，过滤提取物，蒸发乙醇。
-
公开(公告)号：KR1020120000250A
公开(公告)日：2012-01-02
申请号：KR1020100060507
申请日：2010-06-25
Applicant: 한림대학교 산학협력단
IPC: A61K36/185 , A61P35/00
Abstract: PURPOSE: An anti-cancer composition containing Boehmeria spicata Thunb plant extract is provided to induce cell apoptosis of rat-2 fibroblasts and B103 and to be used as an anti-cancer drug. CONSTITUTION: An anti-cancer composition contains Boehmeria spicata Thunb extract as an active ingredient, isolated using water and alcohols of 1-5 carbon atoms. The Boehmeria spicata Thunb includes Boehmeria longispica steud, Boehmeria platanifolia Franch. & Sav., Boehmeria pannosa Nakai & Satake, or Boehmeria tricuspis Makino. A method for preparing the anti-cancer composition comprises: a step of preparing dry Boehmeria spicata Thunb; a step of adding 5-20 times weight of solvent selected among water and alcohols of 1-5 carbon atoms; and a step of isolating.
Abstract translation: 目的：提供含有Boehmeria spicata Thunb植物提取物的抗癌药物，以诱导大鼠-2成纤维细胞和B103的细胞凋亡，并用作抗癌药物。 构成：抗癌组合物含有Boehmeria spicata Thunb提取物作为活性成分，使用1-5个碳原子的水和醇分离。 Boehmeria spicata Thunb包括Boehmeria longispica steud，Boehmeria platanifolia Franch。 ＆Sav。，Boehmeria pannosa Nakai＆Satake或Boehmeria tricuspis Makino。 一种抗癌组合物的制备方法，其特征在于，包括：制备干燥的Boehmeria spicata Thunb; 加入5-20倍重量的选自1-5个碳原子的水和醇的溶剂的步骤; 和隔离的步骤。
-
8.发明公开
公开(公告)号：KR1020150094937A
公开(公告)日：2015-08-20
申请号：KR1020140015862
申请日：2014-02-12
Applicant: 한림대학교 산학협력단
IPC: A61K36/704 , A61K36/70 , A61P35/00
CPC classification number: A61K36/704 , A23V2200/308 , A61K2236/33
Abstract: 본 발명은 쪽(
Persicaria
tinctorium ) 추출물을 유효성분으로 함유하는 뇌종양 예방용 약학 조성물 및 이를 포함하는 건강 기능성 식품 조성물에 관한 것이다.Abstract translation: 本发明涉及用于脑肿瘤预防的药物组合物和含有该组合物的膳食补充剂组合物。 药物组合物包括作为活性成分的Persicaria tinctoria提取物。
-
公开(公告)号：KR1020140086240A
公开(公告)日：2014-07-08
申请号：KR1020120156483
申请日：2012-12-28
Applicant: 한림대학교 산학협력단
CPC classification number: A61K36/36 , A23L33/105 , A23V2002/00 , A23V2200/308
Abstract: The present invention relates to an anticancer agent and a method for producing a health functional food composition including the same, wherein the anticancer agent includes an active ingredient of a caryophyllaceae cowherb (Saponaria vaccaria) seed extract which is a component having a medical action to control the proliferation of brain tumor cells.
Abstract translation: 本发明涉及一种抗癌剂及其制造方法，其中含有该抗癌剂的保健功能性食品组合物，其中，所述抗癌剂包括作为控制药物作用的成分的花椰菜（Saponaria vaccaria）种子提取物的活性成分 脑肿瘤细胞的增殖。
-
公开(公告)号：KR1020130085265A
公开(公告)日：2013-07-29
申请号：KR1020120006301
申请日：2012-01-19
Applicant: 한림대학교 산학협력단
IPC: A01K67/027 , C12N15/63 , C12N15/89
CPC classification number: A01K67/027 , A01K2217/20 , C12N15/63 , C12N15/89
Abstract: PURPOSE: A development of an animal model including human brain tumor by in utero electroporation of a sphingolipid receptor is provided to develop a brain tumor which increases brain pressure and induces various failures. CONSTITUTION: A development of an animal model including human brain tumor uses the overexpression of sphingolipid. A sphingolipid receptor gene expression vector is used when a minute gene infusion technique is used.
Abstract translation: 目的：提供一种包括人类脑肿瘤在内的动物模型，通过在子宫内电穿孔鞘脂受体来开发脑肿瘤，其增加脑压力并引起各种失败。 构成：包括人脑肿瘤在内的动物模型的发展使用鞘脂的过表达。 当使用微小的基因输注技术时，使用鞘脂受体基因表达载体。
-
-
-
-
-
-
-
-
-
Search Results
11
records
(took 0.018 seconds)
